" /> Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 - CISMeF





Preferred Label : Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1;

NCIt synonyms : Acute Myeloid Leukemia with t(8;21)(q22;q22); Acute Myeloid Leukemia with t(8;21)(q22;q22)(AML1(CBFa)/ETO); Acute Myeloid Leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1; Acute Myeloid Leukemia with t 8 21 q22 q22 AML1 CBFa ETO; Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1::RUNX1T1; Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1::RUNX1T1 Fusion; Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 Fusion; Acute Myeloid Leukemia, t(8;21)(q22;q22);

NCIt related terms : AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1; AML with t(8;21)(q22;q22), RUNX1 RUNX1T1; AML with t(8;21)(q22;q22); RUNX1-RUNX1T1;

NCIt definition : An acute myeloid leukemia with t(8;21)(q22; q22.1) giving rise to RUNX1/RUNX1T1 fusion transcript and showing maturation in the neutrophil lineage. The bone marrow and the peripheral blood show large myeloblasts with abundant basophilic cytoplasm, often containing azurophilic granules. This type of AML is associated with good response to chemotherapy and high complete remission rate.;

Alternative definition : NICHD: An acute myeloid leukemia (AML) associated with t(8;21)(q22;q22) resulting in RUNX1-RUNX1T1 fusion protein expression. This is seen in 12% of children with AML.;

Neoplastic status : Malignant;

ICD-O code : 9896/3;

Details


You can consult :


Nous contacter.
01/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.